AU2007331447B2 - Novel compositions and uses thereof - Google Patents

Novel compositions and uses thereof Download PDF

Info

Publication number
AU2007331447B2
AU2007331447B2 AU2007331447A AU2007331447A AU2007331447B2 AU 2007331447 B2 AU2007331447 B2 AU 2007331447B2 AU 2007331447 A AU2007331447 A AU 2007331447A AU 2007331447 A AU2007331447 A AU 2007331447A AU 2007331447 B2 AU2007331447 B2 AU 2007331447B2
Authority
AU
Australia
Prior art keywords
composition
diabetes
hyperglycemia
supplement
glutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007331447A
Other languages
English (en)
Other versions
AU2007331447A1 (en
Inventor
Haruhiko Inufusa
Markus Graf Von Matuschka-Greiffenclau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIMA Foundation
Original Assignee
Tima Found
TIMA Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06026072A external-priority patent/EP1932542A1/en
Application filed by Tima Found, TIMA Foundation filed Critical Tima Found
Publication of AU2007331447A1 publication Critical patent/AU2007331447A1/en
Application granted granted Critical
Publication of AU2007331447B2 publication Critical patent/AU2007331447B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2007331447A 2006-12-15 2007-12-14 Novel compositions and uses thereof Ceased AU2007331447B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87020006P 2006-12-15 2006-12-15
US60/870,200 2006-12-15
EP06026072.6 2006-12-15
EP06026072A EP1932542A1 (en) 2006-12-15 2006-12-15 Antioxidant composition and its use in diabetes
PCT/EP2007/063970 WO2008071790A2 (en) 2006-12-15 2007-12-14 Novel compositions and uses thereof

Publications (2)

Publication Number Publication Date
AU2007331447A1 AU2007331447A1 (en) 2008-06-19
AU2007331447B2 true AU2007331447B2 (en) 2012-09-06

Family

ID=39309971

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007331447A Ceased AU2007331447B2 (en) 2006-12-15 2007-12-14 Novel compositions and uses thereof

Country Status (7)

Country Link
EP (1) EP2117596B1 (https=)
JP (2) JP5580050B2 (https=)
KR (1) KR101487852B1 (https=)
AU (1) AU2007331447B2 (https=)
CA (1) CA2673054C (https=)
EA (1) EA016926B1 (https=)
WO (1) WO2008071790A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
RS56054B1 (sr) * 2009-01-12 2017-09-29 Biokier Inc Smeša i metod za lečenje dijabetesa
AU2010264636B2 (en) 2009-06-26 2013-06-27 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
CN102711800A (zh) 2009-09-23 2012-10-03 拜奥基尔公司 治疗糖尿病的组合物和方法
WO2012095509A1 (en) * 2011-01-14 2012-07-19 Tima Foundation Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2013072441A1 (en) * 2011-11-15 2013-05-23 Tima Foundation Composition for protection against cell-damaging effects
EP2594141A1 (en) * 2011-11-15 2013-05-22 TIMA Foundation Composition for protection against cell-damaging effects
CN103099211A (zh) * 2012-12-21 2013-05-15 洪万雄 一种融合辅酶q10的广谱性一氧化氮保健品
BR112017001038A2 (pt) * 2014-08-08 2017-11-14 Nestec Sa vitamina b2 e seu uso

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0229047B2 (ja) * 1982-05-29 1990-06-27 Snow Brand Milk Prod Co Ltd Tonyobyochiryozai
JPS60126125A (ja) * 1983-12-09 1985-07-05 松下電器産業株式会社 ジユ−サ
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
JP3581157B2 (ja) * 1992-08-19 2004-10-27 株式会社ミツカングループ本社 低耐糖能者用食品
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
JP3669988B2 (ja) * 2001-05-09 2005-07-13 独立行政法人科学技術振興機構 亜鉛含有食品
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2003116486A (ja) * 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
JP2006508096A (ja) * 2002-11-07 2006-03-09 ディーエスエム アイピー アセッツ ビー．ブイ． 没食子酸エピガロカテキンを含む新規な栄養補助組成物
ATE552008T1 (de) * 2002-12-06 2012-04-15 Sunstar Inc Zusammensetzung mit grün- und gelbgemüse sowie hellem gemüse
US20070218106A1 (en) * 2004-02-17 2007-09-20 Matuschka-Greiffenclau Markus Alcohol Metabolism Moderating Composition
JPWO2005110394A1 (ja) * 2004-05-19 2008-03-21 味の素株式会社 糖尿病治療薬
CN101232822B (zh) * 2005-07-29 2012-11-14 蒂马基金会 用于减缓乙醇代谢和用于降低乙醇诱导的疾病风险的组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy

Also Published As

Publication number Publication date
KR20090100385A (ko) 2009-09-23
CA2673054C (en) 2016-05-10
AU2007331447A1 (en) 2008-06-19
EP2117596A2 (en) 2009-11-18
KR101487852B1 (ko) 2015-01-29
WO2008071790A2 (en) 2008-06-19
JP2010513250A (ja) 2010-04-30
EP2117596B1 (en) 2018-01-03
JP5580050B2 (ja) 2014-08-27
JP2014132017A (ja) 2014-07-17
EA200900835A1 (ru) 2009-12-30
CA2673054A1 (en) 2008-06-19
WO2008071790A3 (en) 2008-10-09
EA016926B1 (ru) 2012-08-30

Similar Documents

Publication Publication Date Title
AU2007331447B2 (en) Novel compositions and uses thereof
US11969411B2 (en) Administration of berberine metabolites
EP3873442B1 (en) A composition for weigth loss or weight management comprising beta-hydroxybutyrate and cannabidiol
Naderi et al. Timing, optimal dose and intake duration of dietary supplements with evidence-based use in sports nutrition
AU2020274411B2 (en) Compositions and methods using a combination of calcium and at least one of oleuropein or metabolite thereof
TW200812503A (en) Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US20160346266A1 (en) Reduction or prevention of alcohol reaction with dietary supplements
US20050008722A1 (en) Compositions incorporating(-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
US9603847B2 (en) Compositions and uses thereof
EP2057905A1 (en) Composition for moderating Triglyceride and Cholesterol Levels
CN101610790B (zh) 新颖的组合物及其用途
US20070042020A1 (en) Composition for the treatment of dysfunctional energy metabolism syndrome
Rivlin Vitamin Defi ciencies
CA3252387A1 (en) Compositions comprising a combination of creatine and oleuropein or a metabolite thereof, and their use to improve muscle function
US12521378B2 (en) Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US12171735B2 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
WO2014143192A1 (en) Reduction or prevention of alcohol reaction with dietary supplements
US12533346B2 (en) Administration of berberine metabolites
CA3118317C (en) Administration of butyrate, bete-hydroxybutyrate, cannabidiol, and related compounds in humans
CA3251911A1 (en) Compositions comprising a combination of caffeine and oleuropein or an associated metabolite and their use to improve muscle function

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired